Cargando…
Cholesterol Levels and Statin Use in Patients With Coronary Heart Disease Treated in Primary Care Settings
INTRODUCTION: Therapy with 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins, has proven to be effective in the treatment of lipid disorders. However, statin therapy continues to be underused, even though statins are a relatively safe and well-tolerated class of agents...
Autores principales: | O’Connor, Patrick J, Gray, Richard J, Maciosek, Michael V, Fillbrandt, Kelly M, DeFor, Terese A, Alexander, Charles M, Weiss, Thomas W, Teutsch, Steven M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1364514/ https://www.ncbi.nlm.nih.gov/pubmed/15963307 |
Ejemplares similares
-
Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016) -
Small Dense Low-Density Lipoprotein Cholesterol and Cardiovascular Risk in Statin-Treated Patients with Coronary Artery Disease
por: Ishii, Junnichi, et al.
Publicado: (2022) -
Cholesterol, Statins, and Alzheimer Disease
por: Koudinov, Alexei R, et al.
Publicado: (2005) -
Statins for the Primary Prevention of Coronary Heart Disease
por: Li, Min, et al.
Publicado: (2019) -
Statin therapy in patients with acute coronary syndrome: low-density lipoprotein cholesterol goal attainment and effect of statin potency
por: Chinwong, Dujrudee, et al.
Publicado: (2015)